Invesco Ltd. Celularity Inc Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $223 - $458	399 Added 1.77%	22,881 $14,000
Q4 2022 Feb 13, 2023	SELL	$1.08 - $2.35 $2,894 - $6,298	-2,680 Reduced 10.65%	22,482 $29,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $4,489 - $45,000	10,441 Added 70.93%	25,162 $58,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $41,366 - $190,048	14,721 New	14,721 $50,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.